Literature DB >> 31770611

Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity.

Sabine Jägle1, Maximilian Heeg2, Sarah Grün1, Anne Rensing-Ehl1, Maria Elena Maccari3, Christian Klemann4, Neil Jones5, Kai Lehmberg6, Claudia Bettoni7, Klaus Warnatz8, Bodo Grimbacher9, Ariane Biebl10, Uwe Schauer11, Rosie Hague12, Olaf Neth13, Andrea Mauracher14, Jana Pachlopnik Schmid14, Alexandre Fabre15, Larysa Kostyuchenko16, Marita Führer17, Myriam Ricarda Lorenz17, Klaus Schwarz18, Jan Rohr3, Stephan Ehl19.   

Abstract

Germline STAT3 gain-of-function (GOF) mutations have been linked to poly-autoimmunity and lymphoproliferation with variable expressivity and incomplete penetrance. Here we studied the impact of 17 different STAT3 GOF mutations on the canonical STAT3 signaling pathway and correlated the molecular results with clinical manifestations. The mutations clustered in three groups. Group 1 mutants showed altered STAT3 phosphorylation kinetics and strong basal transcriptional activity. They were associated with the highest penetrance of lymphoproliferation and autoimmunity. Group 2 mutants showed a strongly inducible transcriptional reporter activity and were clinically less penetrant. Group 3 mutants were mostly located in the DNA binding domain and showed the strongest DNA binding affinity despite a poor transcriptional reporter response. Thus, the GOF effect of STAT3 mutations is determined by a heterogeneous response pattern at the molecular level. The correlation of response pattern and clinical penetrance indicates a significant contribution of mutation-determined effects on disease manifestations.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31770611     DOI: 10.1016/j.clim.2019.108316

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

1.  Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.

Authors:  Lia Furlaneto Marega; Janine Schincariol Sabino; Marcus Vinicius Pedroni; Marcelo Teocchi; Carolina Lanaro; Dulcinéia Martins de Albuquerque; Irene Pereira Dos Santos; Fernando Ferreira Costa; Maria Marluce Dos Santos Vilela
Journal:  Immunol Res       Date:  2021-08-14       Impact factor: 2.829

2.  Diagnostic Yield and Therapeutic Consequences of Targeted Next-Generation Sequencing in Sporadic Primary Immunodeficiency.

Authors:  Georgios Sogkas; Natalia Dubrowinskaja; Katharina Schütz; Lars Steinbrück; Jasper Götting; Nicolaus Schwerk; Ulrich Baumann; Bodo Grimbacher; Torsten Witte; Reinhold E Schmidt; Faranaz Atschekzei
Journal:  Int Arch Allergy Immunol       Date:  2021-10-07       Impact factor: 2.749

3.  Evaluation of the putative lymphoma-associated point mutation D427H in the STAT3 transcription factor.

Authors:  Thomas Meyer; Julia Staab; Lena Sophie Behrendsen; Priyanka Rajeev Menon; Muhammad Jawad Khan; Anke Gregus; Oliver Wirths
Journal:  BMC Mol Cell Biol       Date:  2022-06-25

Review 4.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

Review 5.  STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.

Authors:  Christo Tsilifis; Alexandra F Freeman; Andrew R Gennery
Journal:  J Clin Immunol       Date:  2021-05-01       Impact factor: 8.317

6.  Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia.

Authors:  Sara Ciullini Mannurita; Rayan Goda; Ebe Schiavo; Maria Luisa Coniglio; Annachiara Azzali; Ilaria Fotzi; Annalisa Tondo; Veronica Tintori; Stefano Frenos; Maria Chiara Sanvito; Marina Vignoli; Cristina Luceri; Elisabetta Bigagli; Alessia Grassi; Mario Milco D'Elios; Claudio Favre; Eleonora Gambineri
Journal:  Front Immunol       Date:  2021-01-15       Impact factor: 7.561

7.  Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study.

Authors:  Jessica Rojas-Restrepo; Andrés Caballero-Oteyza; Katrin Huebscher; Hanna Haberstroh; Manfred Fliegauf; Baerbel Keller; Robin Kobbe; Klaus Warnatz; Stephan Ehl; Michele Proietti; Bodo Grimbacher
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

Review 8.  Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity.

Authors:  Georgios Sogkas; Faranaz Atschekzei; Ignatius Ryan Adriawan; Natalia Dubrowinskaja; Torsten Witte; Reinhold Ernst Schmidt
Journal:  Cell Mol Immunol       Date:  2021-04-01       Impact factor: 11.530

9.  Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient.

Authors:  Julian Thalhammer; Maria Elena Maccari; Oliver Wegehaupt; Stephan Ehl; Carsten Speckmann
Journal:  J Clin Immunol       Date:  2021-03-29       Impact factor: 8.317

10.  Novel STAT-3 gain-of-function variant with hypogammaglobulinemia and recurrent infection phenotype.

Authors:  Melinda Erdős; Miyuki Tsumura; Judit Kállai; Árpád Lányi; Zoltán Nyul; György Balázs; Satoshi Okada; László Maródi
Journal:  Clin Exp Immunol       Date:  2021-06-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.